Oramed Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

오라메드 파머슈티컬스NASDAQ:ORMP · Nasdaq · Healthcare

$4.55+1.34%

2026-10-05 close · prelim

Oramed Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$13M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy